Quantità

• Aggiungi al carrello

Descrizione

Acquisto di GRUPPO?? Se volete risparmiare contattateci!

Autore: Kaur, Reusch
Editore: Academic Press (Elsevier Group)
Data di Pubblicazione: 2021
Edizione: 1
ISBN: 9780128223185
Pagine: 258

Monoclonal antibodies (mAbs) are naturally occurring complex biomolecules. New engineering methods have turned mAbs into a leading therapeutic modality for addressing immunotherapeutic challenges and led to the rise of mAbs as the dominant class of protein therapeutics. mAbs have already demonstrated a great potential in developing safe and reliable treatments for complex diseases and creating more affordable healthcare alternatives. Developing mAbs into well-characterized antibody therapeutics that meet regulatory expectations, however, is extremely challenging. Obstacles to overcome include the determination and development of physiochemical characteristics such as aggregation, fragmentation, charge variants, identity, carbohydrate structure, and higher-order structure (HOS).